Safety and Efficacy of 21 Gy for High Dose Rate (HDR) Prostate Brachytherapy
Conditions:   Prostate Cancer;   Prostate Neoplasm Intervention:   Radiation: HDR brachytherapy Sponsor:   Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer
Condition:   Prostate Cancer Intervention:   Radiation: HDR brachytherapy as monotherapy Sponsor:   CR-CSSS Champlain-Charles-Le Moyne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

Safety and Efficacy of 21 Gy for High Dose Rate (HDR) Prostate Brachytherapy
Conditions:   Prostate Cancer;   Prostate Neoplasm Intervention:   Radiation: HDR brachytherapy Sponsor:   Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer
Condition:   Prostate Cancer Intervention:   Radiation: HDR brachytherapy as monotherapy Sponsor:   CR-CSSS Champlain-Charles-Le Moyne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

Safety and Efficacy of 21 Gy for High Dose Rate (HDR) Prostate Brachytherapy
Conditions:   Prostate Cancer;   Prostate Neoplasm Intervention:   Radiation: HDR brachytherapy Sponsor:   Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer
Condition:   Prostate Cancer Intervention:   Radiation: HDR brachytherapy as monotherapy Sponsor:   CR-CSSS Champlain-Charles-Le Moyne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

Safety and Efficacy of 21 Gy for High Dose Rate (HDR) Prostate Brachytherapy
Conditions:   Prostate Cancer;   Prostate Neoplasm Intervention:   Radiation: HDR brachytherapy Sponsor:   Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer
Condition:   Prostate Cancer Intervention:   Radiation: HDR brachytherapy as monotherapy Sponsor:   CR-CSSS Champlain-Charles-Le Moyne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

Safety and Efficacy of 21 Gy for High Dose Rate (HDR) Prostate Brachytherapy
Conditions:   Prostate Cancer;   Prostate Neoplasm Intervention:   Radiation: HDR brachytherapy Sponsor:   Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer
Condition:   Prostate Cancer Intervention:   Radiation: HDR brachytherapy as monotherapy Sponsor:   CR-CSSS Champlain-Charles-Le Moyne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

Safety and Efficacy of 21 Gy for High Dose Rate (HDR) Prostate Brachytherapy
Conditions:   Prostate Cancer;   Prostate Neoplasm Intervention:   Radiation: HDR brachytherapy Sponsor:   Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer
Condition:   Prostate Cancer Intervention:   Radiation: HDR brachytherapy as monotherapy Sponsor:   CR-CSSS Champlain-Charles-Le Moyne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

Safety and Efficacy of 21 Gy for High Dose Rate (HDR) Prostate Brachytherapy
Conditions:   Prostate Cancer;   Prostate Neoplasm Intervention:   Radiation: HDR brachytherapy Sponsor:   Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer
Condition:   Prostate Cancer Intervention:   Radiation: HDR brachytherapy as monotherapy Sponsor:   CR-CSSS Champlain-Charles-Le Moyne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

Safety and Efficacy of 21 Gy for High Dose Rate (HDR) Prostate Brachytherapy
Conditions:   Prostate Cancer;   Prostate Neoplasm Intervention:   Radiation: HDR brachytherapy Sponsor:   Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer
Condition:   Prostate Cancer Intervention:   Radiation: HDR brachytherapy as monotherapy Sponsor:   CR-CSSS Champlain-Charles-Le Moyne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

Safety and Efficacy of 21 Gy for High Dose Rate (HDR) Prostate Brachytherapy
Conditions:   Prostate Cancer;   Prostate Neoplasm Intervention:   Radiation: HDR brachytherapy Sponsor:   Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer
Condition:   Prostate Cancer Intervention:   Radiation: HDR brachytherapy as monotherapy Sponsor:   CR-CSSS Champlain-Charles-Le Moyne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

Safety and Efficacy of 21 Gy for High Dose Rate (HDR) Prostate Brachytherapy
Conditions:   Prostate Cancer;   Prostate Neoplasm Intervention:   Radiation: HDR brachytherapy Sponsor:   Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer
Condition:   Prostate Cancer Intervention:   Radiation: HDR brachytherapy as monotherapy Sponsor:   CR-CSSS Champlain-Charles-Le Moyne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2018 Category: Research Source Type: clinical trials

Short Course Vaginal Cuff Brachytherapy in Treating Patients With Stage I-II Endometrial Cancer
Conditions:   Endometrial Clear Cell Adenocarcinoma;   Endometrial Endometrioid Adenocarcinoma;   Endometrial Serous Adenocarcinoma;   Stage I Uterine Corpus Cancer;   Stage IA Uterine Corpus Cancer;   Stage IB Uterine Corpus Cancer;   Stage II Uterine Corpus Cancer;   Uterine C orpus Carcinosarcoma;   Uterine Corpus Sarcoma Interventions:   Radiation: Vaginal Cuff Brachytherapy;   Radiation: Short course vaginal cuff bra...
Source: ClinicalTrials.gov - February 5, 2018 Category: Research Source Type: clinical trials

Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in Patients With Prostate Adenocarcinoma Adverse Intermediate Risk or High Localized Risk
Condition:   To Evaluate the Rate of Digestive and Urinary Toxicity Intervention:   Radiation: prostatic boost in brachytherapy with high dose rate (HDR) Sponsor:   Centre Georges Francois Leclerc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2018 Category: Research Source Type: clinical trials

3D-CRT, Proton, or Brachytherapy APBI in Treating Patients With Invasive and Non-invasive Breast Cancer
Conditions:   Ductal Breast Carcinoma In Situ;   Estrogen Receptor Positive;   Grade 1 Invasive Breast Carcinoma;   Grade 2 Invasive Breast Carcinoma;   Grade 3 Invasive Breast Carcinoma;   Invasive Ductal and Lobular Carcinoma In Situ;   Mucinous Breast Carcinoma;   Tubular  Breast Carcinoma Interventions:   Radiation: 3-Dimensional Conformal Accelerated Partial Breast Irradiation;   Procedure: Interstitial Radiation The...
Source: ClinicalTrials.gov - January 5, 2018 Category: Research Source Type: clinical trials